Skip to main content
. 2018 Dec 20;3(3-4):121–132. doi: 10.3233/TRD-180030

Table 1.

Programs with products granted Regenerative Medicine Advanced Therapy designation between December 13, 2016 and October 1, 2018

RMAT Cell Therapy Products Gene or Genetically Modified Cell Therapy Products Total n (%)
All RMAT programs 18 9 27 (100%)
RMAT programs designed for the treatment of rare diseases 10 7 17 (63%)
RMAT programs with products requiring tissue-specific delivery via device or surgical procedure 11 3 14 (52%)